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Abstract
This study tested the hypothesis that simvastatin treatment can improve cardiovascular and autonomic functions and
membrane lipoperoxidation, with an increased effect when applied to physically trained ovariectomized rats. Ovariectomized
rats were divided into sedentary, sedentary+simvastatin and trained+simvastatin groups (n = 8 each). Exercise training was
performed on a treadmill for 8 weeks and simvastatin (5 mg/kg) was administered in the last 2 weeks. Blood pressure (BP) was
recorded in conscious animals. Baroreflex sensitivity was evaluated by the tachycardic and bradycardic responses to BP
changes. Cardiac vagal and sympathetic effects were determined using methylatropine and propranolol. Oxidative stress was
evaluated based on heart and liver lipoperoxidation using the chemiluminescence method. The simvastatin-treated groups
presented reduced body weight and mean BP (trained+simvastatin = 99 ± 2 and sedentary+simvastatin = 107 ±
2 mmHg) compared to the sedentary group (122 ± 1 mmHg). Furthermore, the trained group showed lower BP and heart rate
compared to the other groups. Tachycardic and bradycardic responses were enhanced in both simvastatin-treated groups. The
vagal effect was increased in the trained+simvastatin group and the sympathetic effect was decreased in the
sedentary+simvastatin group. Hepatic lipoperoxidation was reduced in sedentary+simvastatin (<21%) and trained+sim-
vastatin groups (<57%) compared to the sedentary group. Correlation analysis involving all animals demonstrated that cardiac
lipoperoxidation was negatively related to the vagal effect (r = -0.7) and positively correlated to the sympathetic effect (r =
0.7). In conclusion, improvement in cardiovascular and autonomic functions associated with a reduction of lipoperoxidation with
simvastatin treatment was increased in trained ovariectomized rats.
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Introduction
Cardiovascular diseases remain the leading cause of
death among women in the most developed areas of the
world (1). Studies have demonstrated that menopause
can induce metabolic, endothelial and autonomic dys-
functions and increase oxidative stress in women, thus
increasing cardiovascular risk (2-5). Similarly, rats sub-
jected to ovarian hormone deprivation presented
increased blood pressure (BP) and sympathetic tonus
and reduced baroreflex sensitivity (BRS) compared to
control female rats (6).
On the other hand, simvastatin treatment reduces
both mortality and coronary events in humans, and also
prevents and controls atherosclerosis (7,8). The beneficial
pleiotropic effects of simvastatin treatment may be due to
the endothelial protection, oxidative stress reduction,
sympathetic decrease, and control of inflammatory reac-
tions it seems to offer (9-12).
In addition, exercise training has been recognized as a
non-pharmacological treatment for cardiovascular dis-
ease. A recent systematic review of randomized, con-
trolled trials reported benefits of regular exercise after
menopause (13). Furthermore, previous studies per-
formed in our laboratory have demonstrated that exercise
training induced a reduction in body weight, BP and
cardiac oxidative stress and an increase in BRS in an
experimental model of menopause (6,14,15).
However, there are few data in the literature concerning
the effects of either pharmacological or non-pharmacological
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approaches on hemodynamic, autonomic or oxidative
stress profile changes induced by ovarian hormone
deprivation. Also, there are no data on the effects of the
association of simvastatin treatment with exercise training,
two common approaches used in postmenopausal women
in clinical practice.
Therefore, the purpose of the present study was to
test the hypothesis that short-term simvastatin treatment
(2 weeks) can induce cardiovascular and autonomic
improvement and reduce oxidative stress when evaluated
by membrane lipoperoxidation. Moreover, we hypothe-
sized that simvastatin treatment can induce additional
benefits in physically trained ovariectomized rats.
Material and Methods
Animals and groups
Experiments were performed on 24 female Wistar rats
(215-230 g) from the animal house of the Universidade
Sa˜o Judas Tadeu, Sa˜o Paulo, Brazil. The rats were given
standard laboratory chow and water ad libitum and were
housed in individual cages in a temperature-controlled
room (226C) with a 12-h dark/light cycle. All rats were
treated similarly in terms of daily manipulation. The
experimental protocol was approved by the institutional
Animal Care and Use Committee of Universidade Sa˜o
Judas Tadeu and the investigation was conducted in
accordance with the Guide for the Care and Use of
Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85-23, revised
1985). Ovariectomized rats were randomly assigned to
the following groups: sedentary (SO, n = 8), sedentary
treated with simvastatin (SSO, n = 8), and exercise
trained treated with simvastatin (STO, n = 8).
Ovariectomy
At 10-12 weeks of age, animals were anesthetized
(80 mg/kg ketamine and 12 mg/kg xylazine), and a small
abdominal incision was made. The ovaries were then
located, and a silk thread was tightly tied around the
oviduct, including the ovarian blood vessels. The oviduct
was sectioned and the ovaries removed. The skin and
muscle wall were then sutured with silk thread. After
surgery, the animals received an injection of antibiotics
(40,000 U/kg penicillin G procaine, im) (6,14,16).
Exercise training
Exercise training was performed on a motor treadmill at
low-moderate intensity (<40 to 65% maximal running
speed) for 1 h a day, 5 days a week, for 8 weeks, with a
gradual increase in speed from 0.3 to 1.2 km/h. All animals
were adapted to the procedure (10 min/day, 0.3 km/h) for 1
week before beginning the exercise training protocol. This
adaptation period began 24 h after ovariectomy (6,14). All
groups were subjected to a maximal treadmill test, as
described in detail in a previous publication (17,18). The
tests were performed three times: 1) at the beginning of the
experiment, 2) in the fourth week, and 3) in the eighth week
of the training protocol. The purpose was to determine
maximal physical capacity and exercise training intensity.
Simvastatin treatment
Simvastatin treatment (5 mg kg-1?day-1) was performed
daily by gavage in the last 2 weeks of sedentarism or
training. The SO group was submitted to a daily gavage of
water. The choice of a simvastatin dose of 5 mg kg-1?day-1
was based on a pilot study in which we compared the dose
of 20 mg kg-1?day-1 to a dose of 5 mg kg-1?day-1 in male
rats. The results of these experiments showed that the
dose of 20 mg kg-1?day-1 induced further reduction in
triglycerides and total cholesterol in treated male rats,
which could induce changes in cardiac and autonomic
functions, independently of the pleiotropic effects of
simvastatin. Considering these results and the fact that
the dose of 5 mg/kg did not induce changes in the
metabolic parameters evaluated, for the present experi-
ments we chose the simvastatin dose of 5 mg/kg.
Metabolic evaluations
Body weight was measured at the beginning and at
the end of the protocol. Blood glucose and triglycerides
were evaluated after 4 h fasting at the beginning and at
the end of the protocol using the Roche GCT Accutrend
(Roche, Brazil).
Cardiovascular assessments
After the last training session, 2 catheters filled with
0.06 mL saline were implanted into the carotid artery and
jugular vein (PE-10) of anesthetized rats (80 mg/kg
ketamine and 12 g/kg xylazine) for direct measurement
of BP and for drug administration, respectively. The rats
were conscious and allowed to move freely during the
hemodynamic experiments. The arterial cannula was
connected to a strain-gauge transducer (Blood Pressure
XDCR, Kent Scientific, USA), and blood pressure signals
were recorded over a 30-min period by a microcomputer
equipped with an analog-to-digital converter board
(CODAS, 2-kHz sampling frequency; Dataq Instruments,
Inc., USA). The recorded data were analyzed on a beat-
to-beat basis to quantify changes in mean BP (MBP) and
heart rate (HR). Increasing doses of phenylephrine (0.25
to 32.0 mg/kg, iv) and sodium nitroprusside (0.05 to
1.6 mg/kg, iv) were given as sequential bolus injections
(0.1 mL) to produce pressure responses ranging from 5 to
40 mmHg. A 3- to 5-min interval between doses was
necessary for blood pressure to return to baseline. Peak
increases or decreases in MBP after phenylephrine or
sodium nitroprusside injection and the corresponding
peak reflex changes in HR were recorded for each dose
of the drug. BRS was evaluated by a mean index relating
changes in HR to the changes in MBP to allow for
separate analysis of gain for reflex bradycardia and reflex
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tachycardia. The mean index was expressed as bpm/
mmHg, as described elsewhere (14,15).
Vagal and sympathetic effects were studied by
injecting methylatropine (3 mg/kg, iv) and propranolol
(4 mg/kg, iv) at a dose of 0.1 mL/100 g body weight.
Resting HR was recorded while the rats were in their
cages in an unrestrained state, and methylatropine was
injected immediately after the recording. Because the HR
response to these drugs reaches its peak within 5 min,
this time interval was allowed to elapse before the HR
measurement was made. On the following day, the
sequence of injection was inverted, with propranolol given
first. The sympathetic effect was determined as the
difference between the basal HR and the lowest HR after
propranolol. The vagal effect was obtained by the
difference between the maximum HR after methylatropine
injection and the basal HR (19).
Evaluation of membrane lipoperoxidation
The animals were killed by decapitation and the heart
(ventricles) and liver were immediately removed, rinsed in
saline, and trimmed to remove fat tissue and visible
connective tissue. These tissues were cut into small pieces,
placed in ice-cold buffer, and homogenized in an ultra-
Turrax blender with 1 g tissue per 5 mL 150 mM KCl and
20 nM sodium phosphate buffer, pH 7.4. The homogenates
were centrifuged at 600 g for 10 min at -26C. Tissue
membrane lipoperoxidation was evaluated by chemilumi-
nescence. The chemiluminescence assay was carried out
with an LKB Rack Beta liquid scintillation spectrometer
1215 (LKB Producer AB, USA) in the out-of-coincidence
mode at room temperature (256 to 276C). The supernatants
were diluted in 140 mM KCl and 20 mM sodium phosphate
buffer, pH 7.4, and added to glass tubes, which were
placed in scintillation vials; 3 mM tert-butylhydroperoxide
was added, and chemiluminescence was determined up to
the maximal level of emission (14,20,21).
Statistical analysis
Data are reported as means ± SE. Comparisons
between the 3 groups were performed by one-way
ANOVA followed by the Student-Newman-Keuls post
hoc test. Pearson’s correlation was used to determine
association among variables. The level of significance
was established at P , 0.05.
Results
There were no differences in body weight between
groups at the beginning of the protocol (SO = 207 ±
2.5 g). At the end of the training period, SSO and STO
animals (SSO = 306 ± 5 g; STO = 308 ± 8 g) had a
smaller increase in body weight compared to SO animals
(323 ± 4 g). No difference in blood metabolic parameters
was observed between groups at the beginning of the
protocol. After 4 h of fasting, blood glucose (SO = 89 ±
2 mg/dL) and triglycerides (SO = 97 ± 5 mg/dL) did not
differ between groups at the end of the protocol.
Maximal physical performance was evaluated by the
response to the maximal treadmill test. At the beginning of
the experiment, the physical performance was similar for
all groups (SO = 2 ± 0.08 km/h). However, the animals
submitted to the exercise training protocol (STO = 2.4 ±
0.09 km/h) showed an increase in maximum running
speed compared to the SO (2 ± 0.09 km/h) and SSO (1.9
± 0.07 km/h) groups after 8 weeks of exercise training.
Simvastatin treatment associated or not with exercise
training induced reduction in systolic BP (SBP; STO =
120 ± 3 and SSO = 123 ± 2 vs SO = 140 ± 2 mmHg;
P , 0.001), diastolic BP (DBP; STO = 82 ± 2 and SSO
= 92± 2 vs SO= 104 ± 2 mmHg; P, 0.001) and MBP
(STO = 99 ± 2 and SSO = 107 ± 2 vs SO = 122 ±
1 mmHg; P , 0.001). The exercise training associated
with simvastatin treatment (STO) induced an additional
reduction in MBP compared to the animals treated with
simvastatin alone (SSO) (Figure 1A). HR was lower in
trained rats (STO = 329 ± 6 bpm) when compared to
sedentary rats treated or not with simvastatin (SSO =
366 ± 8 and SO = 374 ± 7 bpm) (Figure 1B).
The tachycardic (SSO= 3.5 ± 0.2 and STO= 3.4 ±
0.2 vs SO = 2.7 ± 0.2 bpm/mmHg) and the bradycardic
(SSO = -1.6 ± 0.10 and STO = -1.6 ± 0.15 vs SO =
-1.2 ± 0.1 bpm/mmHg) responses evoked by the barore-
flex during BP reductions and increases, respectively, were
increased in rats treated with simvastatin, regardless of any
association with exercise training, when compared to
sedentary ovariectomized rats (SO; Figure 2A).
The vagal effect was increased in trained rats (STO =
99 ± 21 bpm) compared to sedentary rats treated or not
Figure 1.Mean arterial pressure (MAP; A) and heart rate (HR; B)
of sedentary ovariectomized rats (SO), sedentary ovariectomized
rats treated with simvastatin (SSO), and trained ovariectomized
rats treated with simvastatin (STO). *P , 0.05 vs SO group; +P
, 0.05 vs SSO group (one-way ANOVA followed by the Student-
Newman-Keuls test).
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with simvastatin (SO = 55 ± 5 and SSO = 67 ± 6 bpm).
However, the sympathetic effect was decreased in seden-
tary rats treated with simvastatin (SSO = 28 ± 4 bpm)
compared to sedentary rats (SO=54±6 bpm; Figure 2B).
Oxidative stress evaluated by membrane lipoperoxida-
tion showed a significant reduction in liver homogenates
from animals submitted to simvastatin treatment (<21%)
and from animals submitted to exercise training associated
with simvastatin treatment (<57%) compared to the
sedentary group (SO). No difference in cardiac lipoperox-
idation was observed between the two groups (Table 1).
Correlation analysis involving all animals studied
demonstrated that cardiac lipoperoxidation was nega-
tively related to the vagal effect (r = -0.7; r2 = 0.49; P ,
0.05) and positively correlated to the sympathetic effect
(r = 0.7; r2 = 0.49; P , 0.05).
Discussion
Important insights were obtained in the present study.
Firstly, although the simvastatin-treated ovariectomized
rats, either trained or not, showed unchanged blood
triglycerides and glucose levels (after 4 h of fasting), they
indeed presented decreased body weight, SBP, DBP, and
MBP compared to sedentary ovariectomized rats.
Secondly, simvastatin treatment of sedentary or trained
ovariectomized rats induced improved bradycardic and
tachycardic baroreflex responses compared to sedentary
untreated rats, a fact possibly related to a decrease in
cardiac sympathetic effect (sedentary group treated with
simvastatin) or with an increase in vagal effect on the
heart (trained group). Thirdly, simvastatin treatment of
ovariectomized animals (SSO and STO groups) induced a
reduction in membrane lipoperoxidation of the liver, the
target organ for the lipid-regulating effect of this drug.
Fourthly and importantly, the BP and liver lipoperoxidation
reductions in the simvastatin-treated groups were more
pronounced in trained rats and were accompanied by
resting bradycardia and improved physical capacity.
Finally, the levels of cardiac lipoperoxidation were
correlated with the autonomic control of HR, suggesting
that improved autonomic cardiac control could be
associated with reduced oxidative stress in the heart.
The incidence of cardiovascular disease in women
increases sharply after menopause and probably involves
changes in BP and its regulation associated with estrogen
loss (2-3). In the present study, we showed elevated BP
values in ovariectomized rats when compared to BP
values previously found not only in intact female rats but
also in male rats (6,16,21-23). In fact, ovariectomized rats
showed an increase in BP values, reaching values similar
to the ones observed in our experiments (6). Moreover,
some previous studies have not shown a decrease in BP
values after simvastatin treatment in male rabbits, rats or
humans (9,24-26). In the present study, we showed a
decrease in BP after simvastatin treatment, corroborating
previous data that demonstrated BP reduction after long-
term simvastatin treatment (27,28). Reduction in BP
values after training was reported in normotensive
postmenopausal women (13,29). Moreover, previous
studies have shown that low- to moderate-intensity
exercise training is an efficient nonpharmacological
treatment for hypertension (30-32). This is the first study
to demonstrate that simvastatin treatment in trained rats
increases the BP reduction observed in rats only exposed
to this pharmacological approach.
The mechanisms involved in BP reduction may be
related to changes in cardiac output or peripheral
resistance. It is well established that increased oxidative
stress plays an important role in endothelial and cardiac
dysfunctions, which are involved in the vasomotor and
cardiac tonus. It is important to emphasize that an
additional BP reduction was observed in STO animals.
Figure 2. Baroreflex sensitivy (BRS) evaluated by bradycardic
and tachycardic responses to blood pressure changes (A) and
autonomic control of heart rate (HR) reflected in vagal and
sympathetic effects (B) in sedentary ovariectomized rats (SO),
sedentary ovariectomized rats treated with simvastatin (SSO)
and trained ovariectomized rats treated with simvastatin (STO).
*P , 0.05 vs SO group; +P , 0.05 vs SSO group (one-way
ANOVA followed by the Student-Newmann-Keuls test).
Table 1. Oxidative stress evaluated by chemiluminescence (CL)
in sedentary ovariectomized rats (SO), sedentary ovariectomized
rats treated with simvastatin (SSO), and trained ovariectomized
rats treated with simvastatin (STO).
SO SSO STO
CL (cps/mg protein)
Heart 6614 ± 392 5236 ± 339 5244 ± 230
Liver 2511 ± 428 1985 ± 538* 1068 ± 203*
Data are reported as means ± SE. *P , 0.05 vs SO group (one-
way ANOVA followed by the Student-Newmann-Keuls test).
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This change may be associated with the resting brady-
cardia observed in this group, which could induce a
reduction in cardiac output. In fact, some investigators
(33) have reported that exercise training causes a
reduction in cardiac output in hypertensive subjects,
whereas others (30) have observed a decrease in total
peripheral resistance in humans. The resting bradycardia
verified in the trained ovariectomized rats treated with
simvastatin can be attributed to the increased cardiac
vagal tonus obtained in this group as previously docu-
mented in males and ovariectomized females (6,15,19).
BRS dysfunction has been documented in cardiovas-
cular diseases as an important predictor of mortality and
survival (34). Thus, the identification of the mechanism
underlying a depressed BRS, as well as the study of
therapies to improve this cardiovascular reflex, have
important clinical implications. Davy et al. (35) have reported
that physically active postmenopausal women present
higher BRS when compared to age-matched less active
women, providing insights into a possible cardioprotective
mechanism in physically active postmenopausal women.
Pliquett et al. (9) have also shown baroreflex improvement in
rabbits with heart failure after statin treatment without
changes in total plasma or high-density cholesterol. In the
present study, we demonstrated that simvastatin treatment,
associated or not with exercise training in an experimental
model of ovarian hormone deprivation, induced an improve-
ment in BRS for both the bradycardic and tachycardic
responses evoked by BP rises and falls, respectively.
The improvement in this important cardiovascular reflex
could be due to changes in the efferent pathways, since the
vagal effect was increased in the trained group and the
sympathetic effect was decreased in the sedentary simvas-
tatin group. Moreover, the BP reduction may have con-
tributed to improving the sensitivity of this reflex. However,
additional changes in afferent pathways (36) or in the central
component of this reflex should not be excluded.
Studies from our laboratory have shown an increase in
cardiac vagal activity in trained mice and rats (6,15,19).
Corroborating these data, in the present study we showed
an increased vagal effect in the group subjected to both
treatments (simvastatin+exercise). Other studies, how-
ever, have reported that exercise training decreased or had
no effect on sympathetic activity in spontaneously hyper-
tensive rats and in healthy and ovariectomized female rats
(6,15,23,31). Moreover, Gentlesk et al. (37) have demon-
strated a reduction in cardiac death after simvastatin
treatment, which was attributed to changes in sympathetic
modulation. In the present study, we observed a decrease
in sympathetic effect in simvastatin-treated rats.
Importantly, these beneficial changes in cardiac
autonomic control observed in the simvastatin groups,
trained or not, were related to reduced cardiac oxidative
stress as evaluated by membrane lipoperoxidation.
Exercise training (14,21,32) and simvastatin (38) have
been reported as therapies, which improve the antioxidant
mechanism and reduce oxidative stress. Corroborating
these data, we observed reduced hepatic lipoperoxidation
in the simvastatin-treated groups (trained or not) com-
pared to the untreated group, but no significant changes
were obtained in cardiac lipoperoxidation. Two aspects
deserve a special note: first, the trained group presented
about 50% reduction in hepatic lipoperoxidation compared
to the sedentary group treated with simvastatin alone.
This suggests an additional effect obtained by associating
the therapies. Second, despite the fact that cardiac
lipoperoxidation was similar in all groups studied, the
correlations observed between cardiac lipoperoxidation
and sympathetic and parasympathetic effects suggest
that the animals presenting a decreased sympathetic
effect and/or increased vagal effect also presented lower
cardiac membrane lipoperoxidation. In the present study,
correlation analysis (r2) showed that cardiac lipoperoxida-
tion variability explained 50-60% of cardiac sympathetic or
vagal effect variability. This reinforces the role of oxidative
stress in cardiovascular autonomic dysfunction as pre-
viously reported by our group (14,32).
Importantly, the trained females treated with simvasta-
tin showed a marked increase in estimated physical
capacity as evaluated by their response to the maximal
exercise test, indicating that the training protocol used was
effective. Significant correlation between oxygen consump-
tion and maximum running velocity was reported in
untrained rats (17,18). Furthermore, the findings for resting
bradycardia and reduced body weight are also good
indications of the efficacy of the exercise training protocol
in promoting overall fitness. In a recent review, Asikainen
et al. (13) have shown that 9 studies on postmenopausal
women have reported improvement in exercise capacity
and body weight reduction after regular physical activity.
The improvement in cardiac autonomic control after
short-term simvastatin treatment in an experimental
model of ovarian hormone deprivation in the present
study was independent of the classical plasma lipid
effects of this drug, thus reinforcing the hypothesis that
statin would reduce cardiovascular risk in females. These
autonomic pleiotropic effects of statins may account for
the patients’ outcome and should be further character-
ized. In this respect, compelling evidence suggests that
statins have beneficial effects on survival, even for normal
lipid levels (8,39). However, additional studies are needed
to confirm the pleiotropic effects of long-term statin
treatment as well as the additional effects of associated
physical training on the autonomic dysfunction and on the
outcome of women in the climacterium.
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